Biosceptre
Signal active
Organization
Contact Information
Overview
Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from a wide range of malignancies.
About
Industries
Biotechnology, Life Science, Pharmaceutical
Founded
2000
Employees
11-50
Headquarters locations
Europe
Social
N/A
Profile Resume
Biosceptre headquartered in Europe, operates in the Biotechnology, Life Science, Pharmaceutical sector. The company focuses on Biotechnology and has secured $1.6B in funding across 60 round(s). With a team of 11-50 employees, Biosceptre is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Biosceptre, raised $4.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
0
Lead Investors
0
Total Funding Amount
$26.0M
Details
3
Biosceptre has raised a total of $26.0M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2017 | Early Stage Venture | 10.7M | ||
| 2016 | Seed | 1.0M | ||
| 2023 | Early Stage Venture |
Investors
Biosceptre is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Mark Gillespie | - | FUNDING ROUND - Mark Gillespie | undefined |
| Norcliffe Capital | - | FUNDING ROUND - Norcliffe Capital | 9.6M |
| Biosceptre | - | FUNDING ROUND - Biosceptre | 9.6M |
| Jungle Capital | - | FUNDING ROUND - Jungle Capital | 9.6M |
Recent Activity
There is no recent news or activity for this profile.